Key result
Flunarizine significantly increased cycle length and terminated ventricular tachycardia induced by ouabain (P<=0.001), but had no significant effect on ischemia-induced ventricular tachycardia.
Why the study?
Does flunarizine alter the cycle length and terminate ventricular tachycardia differently based on the underlying arrhythmia mechanism in a canine model?
Does flunarizine alter the cycle length and terminate ventricular tachycardia differently based on the underlying arrhythmia mechanism in a canine model?
p-value: p=<=0.001
Flunarizine effectively terminates ventricular tachycardia caused by triggered activity (ouabain intoxication) but not abnormal automaticity (ischemia), suggesting utility in differentiating arrhythmia mechanisms in vivo.
No takes yet. Share an insight, caveat, or question.
May aid mechanistic differentiation in canine models; leaves open translation to clinical arrhythmia management.
Vos et al. (1990) studied Ventricular tachycardia (n=34). Flunarizine vs. Baseline (before flunarizine) was evaluated on Cycle length of the different rhythms before and after flunarizine (p=<=0.001). Flunarizine significantly increased cycle length and terminated ventricular tachycardia induced by ouabain (P<=0.001), but had no significant effect on ischemia-induced ventricular tachycardia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: